Major components of the direct medical costs of alpha1-antitrypsin deficiency.

Abstract excerpt

STUDY OBJECTIVES: To examine the sources of the direct medical costs of alpha(1)-antitrypsin (AAT) deficiency based on survey data from affected individuals. BACKGROUND: Prior research has reported the total cost of AAT deficiency but has not examined the specific components of the direct medical costs of affected individuals. METHODS: In order to detail the sources of the direct medical costs, we sent surveys to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to alpha 1-Antitrypsin Deficiency
• Share to Costs and Cost Analysis
• Share to Health Care Costs